TD Cowen Reiterates Buy Rating on Procept BioRobotics Corp (PRCT)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to TD Cowen Reiterates Buy Rating on Procept BioRobotics Corp (PRCT)

Procept BioRobotics Corp (PRCT) PT Raised to $94 at BofA Securities

August 22, 2024 5:36 AM EDT

BofA Securities analyst Bob Hopkins raised the price target on Procept BioRobotics Corp (NASDAQ: PRCT) to $94.00 (from $80.00) while maintaining a Buy rating.

The analyst comments "This morning, PRCT announced that it received FDA clearance for Hydros its next generation robot for benign prostatic... More

PROCEPT BioRobotics Corporation (PRCT) Announces FDA Clearance of the HYDROS Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

August 21, 2024 7:02 AM EDT

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the Company), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced FDA 510(k) clearance of its next-generation platform, the HYDROS Robotic System. Leveraging insights from over 50,000 procedures, HYDROS features FirstAssist AI treatment planning, advanced image guidance, robotic resection, and a streamlined workflow. HYDROS is... More